Research progress of CD80 in the development of immunotherapy drugs
2024

Research Progress of CD80 in Immunotherapy

publication 10 minutes Evidence: moderate

Author Information

Author(s): Li Lanying, Yang Lei, Jiang DePeng

Primary Institution: The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China

Hypothesis

CD80 plays a crucial role in T cell activation and can be targeted for immunotherapy in tumors and autoimmune diseases.

Conclusion

CD80 is a promising target for developing immunotherapy drugs due to its significant role in T cell activation and regulation of immune responses.

Supporting Evidence

  • CD80 is expressed on various immune cells and tumor cells, playing a key role in T cell activation.
  • Targeting CD80 can enhance anti-tumor immunity and may improve outcomes in cancer treatment.
  • CD80's interaction with PD-L1 and CTLA-4 provides insights into its dual role in immune activation and suppression.

Takeaway

CD80 helps our immune system fight cancer and autoimmune diseases, and scientists are studying how to use it to make better medicines.

Methodology

This review summarizes the role of CD80 in the immune system and its potential applications in immunotherapy.

Limitations

The review does not provide specific experimental data or clinical trial results.

Digital Object Identifier (DOI)

10.3389/fimmu.2024.1496992

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication